Literature DB >> 19779725

The Hebrew version of the FibroFatigue scale: validation of a questionnaire for assessment of fibromyalgia and chronic fatigue syndrome.

Jacob N Ablin1, Lisa Odes, Lily Neumann, Dan Buskila.   

Abstract

The objective of this study is to validate a translated Hebrew version of the FibroFatigue Scale (FFS). The Hebrew version of the FFS was administered to 100 patients fulfilling ACR criteria for classification of FM together with the validated Hebrew version of the Fibromyalgia Impact Questionnaire (FIQ), the validated Hebrew version of the Short Form-36 (SF-36) and a Visual Analogue Scale (VAS) measurement of pain, anxiety, depression, morning stiffness and global well being. Test-retest reliability was assessed using Spearman correlations. Internal consistency was evaluated with Cronbach's alpha of reliability. Construct validity of the FFS was evaluated by correlations among the FFS, the FIQ and the subscales of the SF-36. Mean duration of symptoms was 10.7 years, and mean age of participants was 53.5 years. Test-retest reliability was between 0.46 and 0.85 for the various FFS items. Internal consistency was 0.89 for the overall FFS. Significant correlations were obtained between the FFS items and the SF-36. These results support the reliability and validity of the data obtained with the Hebrew version of the FSS for detecting and measuring symptom severity in Hebrew speaking patients with FM.

Entities:  

Mesh:

Year:  2009        PMID: 19779725     DOI: 10.1007/s00296-009-1122-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Evaluation of a Hebrew version of the revised and expanded Arthritis Impact Measurement Scales (AIMS2) in patients with fibromyalgia.

Authors:  L Neumann; Y Dudnik; A Bolotin; D Buskila
Journal:  J Rheumatol       Date:  1999-08       Impact factor: 4.666

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Validation of the 36-item short-form Health Survey (Hebrew version) in the adult population of Israel.

Authors:  N Lewin-Epstein; T Sagiv-Schifter; E L Shabtai; A Shmueli
Journal:  Med Care       Date:  1998-09       Impact factor: 2.983

4.  A comprehensive psychopathological rating scale.

Authors:  M Asberg; S A Montgomery; C Perris; D Schalling; G Sedvall
Journal:  Acta Psychiatr Scand Suppl       Date:  1978

5.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

6.  Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36).

Authors:  L Neumann; A Berzak; D Buskila
Journal:  Semin Arthritis Rheum       Date:  2000-06       Impact factor: 5.532

7.  Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support.

Authors:  R P Riemsma; J J Rasker; E Taal; E N Griep; J M Wouters; O Wiegman
Journal:  Br J Rheumatol       Date:  1998-10

Review 8.  Chronic widespread pain and fibromyalgia: what we know, and what we need to know.

Authors:  Daniel J Clauw; Leslie J Crofford
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-08       Impact factor: 4.098

9.  Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer-a comparative cross-sectional study of fatigue intensity and characteristics.

Authors:  Carina Lundh Hagelin; Yvonne Wengström; Carl Johan Fürst
Journal:  Support Care Cancer       Date:  2008-09-13       Impact factor: 3.603

10.  Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.

Authors:  Jon I Russell; Philip J Mease; Timothy R Smith; Daniel K Kajdasz; Madelaine M Wohlreich; Michael J Detke; Daniel J Walker; Amy S Chappell; Lesley M Arnold
Journal:  Pain       Date:  2008-04-18       Impact factor: 6.961

View more
  3 in total

1.  Relationship between patient ethnicity and prevalence of anemia during pregnancy and the puerperium period and compliance with healthcare recommendations - implications for targeted health policy.

Authors:  Enav Yefet; Avishag Yossef; Manal Massalha; Abeer Suleiman; Aliza Hatokay; Moria Kamhine-Yefet; Zohar Nachum
Journal:  Isr J Health Policy Res       Date:  2020-11-30

Review 2.  Dissecting the fatigue experience: A scoping review of fatigue definitions, dimensions, and measures in non-oncologic medical conditions.

Authors:  Ruel Billones; Josephine K Liwang; Kierra Butler; Letitia Graves; Leorey N Saligan
Journal:  Brain Behav Immun Health       Date:  2021-05-21

3.  Towards Tailored Patient's Management Approach: Integrating the Modified 2010 ACR Criteria for Fibromyalgia in Multidimensional Patient Reported Outcome Measures Questionnaire.

Authors:  Yasser El Miedany; Maha El Gaafary; Sally Youssef; Ihab Ahmed
Journal:  Arthritis       Date:  2016-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.